Samsara BioCapital, L.P.

13D and 13G Filings

13D/G filings
13D on 9 securities, 13G on 9 securities
Location
Palo Alto, CA
CIK
0001699737
Form D filings
4 filings
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13D · 9 securities · may seek to influence control
Rani Therapeutics Holdings, Inc 13D/A
RANI · 753018100
9.9% 5/28/2026
Event 5/26/2026
Kalaris Therapeutics, Inc. 13D/A
KLRS · 482929106
54.2% 5/22/2026
Event 5/20/2026
Alumis Inc. 13D/A
ALMS · 022307102
5.4% 1/13/2026
Event 1/9/2026
vTv Therapeutics Inc. 13D/A
VTVT · 918385204
9.9% 12/9/2025
Event 12/8/2025
Nkarta, Inc. 13D/A
NKTX · 65487U108
4.9% 11/24/2025
Event 11/20/2025
Inventiva S.A. 13D/A
IVA · 46124U107
7.4% 11/19/2025
Event 11/17/2025
Scholar Rock Holding Corp 13D/A
SRRK · 80706P103
7.2% 10/7/2025
Event 10/3/2025
Mineralys Therapeutics, Inc. 13D/A
MLYS · 603170101
8.2% 9/8/2025
Event 9/4/2025
Syros Pharmaceuticals, Inc. 13D/A
SYRS · 87184Q206
2.6% 3/27/2025
Event 11/18/2024
Schedule 13G · 9 securities · passive
PMV Pharmaceuticals, Inc. 13G
PMVP · 69353Y103
9.9% 9/15/2026
Event 9/2/2026
Eloxx Pharmaceuticals, Inc. 13G
ELOX · 29014R301
9.9% 8/14/2026
Event 6/10/2026
Sutro Biopharma, Inc. 13G
STRO · 869367201
6.4% 5/15/2026
Event 2/11/2026
Spyglass Pharma, Inc. 13G
SGP · 85220G109
6.3% 2/17/2026
Event 2/9/2026
CARGO Therapeutics, Inc. 13G/A
CRGX · 14179K101
0% 11/14/2025
Event 9/30/2025
Leap Therapeutics, Inc. 13G/A
CYPH · 52187K200
0% 8/14/2025
Event 6/30/2025
OnKure Therapeutics, Inc. 13G/A
OKUR · 68277Q105
0% 8/14/2025
Event 6/30/2025
Palvella Therapeutics, Inc. 13G/A
PVLA · 697947109
3.1% 8/14/2025
Event 6/30/2025
IO Biotech, Inc. 13G/A
IOBTQ · 449778109
3.8% 2/14/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.